Signals
Liver Cancer Is Moving Beyond TACE Alone
EMERALD-3 showed that adding the STRIDE immunotherapy regimen to TACE improved progression-free survival in embolization-eligible unresectable hepatocellular carcinoma. The result could shift practice, but the toxicity and implementation questions are not small.
West Nile Is Back. Blood Safety Cannot Lag.
Deep learning uncovers a new ECG biomarker for sudden cardiac death
Half of CKM patients go untreated and most fail control
The Trial Has Started. Now the System Has to Find the Children.
Sleep is now cardiovascular prevention. Health systems still treat it like lifestyle advice
The GLP-1 boom still needs exercise policy
ADHD Does Not Stop Being ADHD When Anxiety Walks Into the Room
Pharmacists are becoming the front door for cardiometabolic care. Policy is still treating them like the back office
Dementia prevention has a cardiometabolic blind spot
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.